Home NDC 49702-231 Triumeq
Product NDC 49702-231
11-digit product format 497020231
Labeler code 49702
Product ID 49702-231_4018a8c7-db0d-481e-b50a-a469ba32ec4b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name abacavir sulfate, dolutegravir sodium, lamivudine
Dosage form TABLET, FILM COATED
Route ORAL
Labeler ViiV Healthcare Company
Application NDA205551
Marketing category NDA
Marketing start 2014-08-22
Substance ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
Active strength 600; 50; 300 mg/1; mg/1; mg/1
Pharmacologic classes Cytochrome P450 1A1 Inhibitors [MoA], HIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205551-001 TRIUMEQ ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 N205551-001 8129385*PED 2028-04-05 Pediatric extension N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 N205551-001 9242986*PED 2030-06-08 Pediatric extension
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N205551-001 M-294 2026-06-15 N205551-001 PED 2026-12-15
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N205551-001 TRIUMEQ EQ 600MG BASE;EQ 50MG BASE;300MG TABLET / ORAL RLD, RS 2014-08-22 cb3db0bc1861…
Observed Orange Book patent history# Patent history page 1 of 4 · 124 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205551-001 8129385*PED 2028-04-05 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205551-001 9242986*PED 2030-06-08 Pediatric extension 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205551-001 8129385*PED 2028-04-05 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205551-001 9242986*PED 2030-06-08 Pediatric extension 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205551-001 8129385*PED 2028-04-05 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205551-001 9242986*PED 2030-06-08 Pediatric extension 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205551-001 8129385*PED 2028-04-05 Pediatric extension fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205551-001 9242986*PED 2030-06-08 Pediatric extension fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205551-001 8129385*PED 2028-04-05 Pediatric extension b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205551-001 9242986*PED 2030-06-08 Pediatric extension b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205551-001 8129385*PED 2028-04-05 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205551-001 9242986*PED 2030-06-08 Pediatric extension 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205551-001 8129385*PED 2028-04-05 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205551-001 9242986*PED 2030-06-08 Pediatric extension 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205551-001 8129385*PED 2028-04-05 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205551-001 9242986*PED 2030-06-08 Pediatric extension 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205551-001 8129385*PED 2028-04-05 Pediatric extension d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205551-001 9242986*PED 2030-06-08 Pediatric extension d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N205551-001 8129385 2027-10-05 Drug substance, Drug product 2014-09-16 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N205551-001 8129385*PED 2028-04-05 Pediatric extension d06236e962d9…2024-10-29 15:01 UTC 2024-10 N205551-001 9242986 2029-12-08 Drug substance, Drug product 2016-03-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N205551-001 9242986*PED 2030-06-08 Pediatric extension d06236e962d9…
Observed Orange Book exclusivity history# Additional Listing Data#
Finished product Yes
Brand name base Triumeq
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ABACAVIR SULFATE 600 mg/1 DOLUTEGRAVIR SODIUM 50 mg/1 LAMIVUDINE 300 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination J220T4J9Q2 Internal UNII lookup 1Q1V9V5WYQ Internal UNII lookup 2T8Q726O95 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1546888 Internal RxNorm lookup 1546894 Internal RxNorm lookup 2598348 Internal RxNorm lookup 2598352 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 49702-231-13 Triumeq 30 in 1 BOTTLE TABLET, FILM COATED 30 30
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ABACAVIR SULFATE ACTIVE INGREDIENT J220T4J9Q2 TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 DOLUTEGRAVIR SODIUM ACTIVE INGREDIENT 1Q1V9V5WYQ TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 LAMIVUDINE ACTIVE INGREDIENT 2T8Q726O95 TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 ABACAVIR ACTIVE MOIETY WR2TIP26VS TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 DOLUTEGRAVIR ACTIVE MOIETY DKO1W9H7M1 TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 LAMIVUDINE ACTIVE MOIETY 2T8Q726O95 TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 MANNITOL INACTIVE INGREDIENT 3OWL53L36A TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 POLYVINYL ALCOHOL INACTIVE INGREDIENT 532B59J990 TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 POVIDONES INACTIVE INGREDIENT FZ989GH94E TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 SODIUM STARCH GLYCOLATE TYPE A CORN INACTIVE INGREDIENT AG9B65PV6B TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 TALC INACTIVE INGREDIENT 7SEV7J4R1U TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 49702-231 TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED TRIUMEQ PD (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) KIT [VIIV HEALTHCARE COMPANY] 27 Current NDC, Legacy NDC, 1 package rows 20240711_2997739a-aa91-42aa-a206-a70e2db7b84f.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Triumeq ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE ViiV Healthcare Company 2997739a-aa91-42aa-a206-a70e2db7b84f 2024-07-08 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 205551 application number: NDA205551 ndc (product): 49702-231
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 49702-231-13 49702023113 30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13) 2014-08-22 0000-00-00 No No Current